Company Filing History:
Years Active: 2002
Title: Klaus Stöckemann: Innovator in Pharmaceutical Development
Introduction
Klaus Stöckemann is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of agents for women's health. With a total of 2 patents, his work focuses on addressing critical issues related to dysfunctional uterine bleeding and female contraception.
Latest Patents
Stöckemann's latest patents include innovative solutions for treating dysfunctional uterine bleeding. One patent describes the use of competitive progesterone antagonists (antigestagens) for the production of pharmaceutical agents aimed at treating forms of dysfunctional uterine bleeding, such as metrorrhagias, menorrhagias, and hypermenorrhea. Another patent outlines the use of compounds with progesterone-antagonistic and antiestrogenic actions, which can be combined in a single dosage unit for female contraception without inhibiting ovulation.
Career Highlights
Klaus Stöckemann has been associated with Schering Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work has been instrumental in advancing treatments that improve women's health and reproductive choices.
Collaborations
Stöckemann has collaborated with notable colleagues, including Kristof Chwalsz and Kristof Chwalisz, contributing to a dynamic research environment that fosters innovation in pharmaceutical development.
Conclusion
Klaus Stöckemann's contributions to the pharmaceutical field, particularly in women's health, highlight his role as an influential inventor. His patents reflect a commitment to improving treatment options and advancing medical science.